AlphaGrep UK’s HCA Healthcare HCA Stock Holding History

AlphaGrep UK’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Buy	2,767 +1,528	+123%	+$646K	0.32%	32
2026 Q1	$586K	Sell	1,239 -494	-29%	-$249K	0.17%	169
2025 Q4	$809K	Buy	+1,733	New	+$805K	0.27%	63

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AlphaGrep UK's HCA Position: Q2 2026 in Review

AlphaGrep UK increased its HCA Healthcare (HCA) stake by 123% in Q2 2026, buying an estimated $646K and bringing the position to 2,767 shares worth $1.08M. The position accounts for 0.32% of the portfolio, ranked #32.

AlphaGrep UK first reported a position in HCA in Q4 2025 and has held it in 3 quarters since. 1,271 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

AlphaGrep UK held 2,767 shares of HCA Healthcare worth $1.08M as of Q2 2026.
AlphaGrep UK bought 1,528 HCA Healthcare shares in Q2 2026, an estimated $646K.
HCA Healthcare made up 0.32% of AlphaGrep UK's portfolio in Q2 2026, its #32 holding.
AlphaGrep UK first reported a position in HCA Healthcare in Q4 2025 and has held it in 3 quarters since.
1,271 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.